NCT00462644View on ClinicalTrials.gov

Evaluation of Etomidate on Adrenal Function in Trauma Patients

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

September 30, 2006

Conditions
Adrenal Insufficiency
Interventions
DRUG

RSI sedation with etomidate/succinylcholine

etomidate 0.3 mg/kg IV plus succinylcholine 1 mg/kg IV

DRUG

RSI sedation with fentanyl/midazolam/succinylcholine

100 micrograms fentanyl IV, plus 5 mg midazolam IV, plus 1 mg/kg succinylcholine IV

Trial Locations (1)

37403

Erlanger Medical Center, Chattanooga

All Listed Sponsors
lead

University of Tennessee

OTHER

NCT00462644 - Evaluation of Etomidate on Adrenal Function in Trauma Patients | Biotech Hunter | Biotech Hunter